Annual EBIT
-$465.61 M
+$111.40 M+19.31%
31 December 2023
Summary:
Ascendis Pharma A/S annual earnings before interest & taxes is currently -$465.61 million, with the most recent change of +$111.40 million (+19.31%) on 31 December 2023. During the last 3 years, it has fallen by -$15.96 million (-3.55%). ASND annual EBIT is now -7538.65% below its all-time high of $6.80 million.ASND EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$80.10 M
+$16.30 M+16.91%
01 September 2024
Summary:
Ascendis Pharma A/S quarterly earnings before interest & taxes is currently -$80.10 million, with the most recent change of +$16.30 million (+16.91%) on 01 September 2024. Over the past year, it has dropped by -$1.85 million (-2.36%). ASND quarterly EBIT is now -3768.43% below its all-time high of $2.18 million, reached on 31 December 2013.ASND Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$310.54 M
+$69.13 M+18.21%
01 September 2024
Summary:
Ascendis Pharma A/S TTM earnings before interest & taxes is currently -$310.54 million, with the most recent change of +$69.13 million (+18.21%) on 01 September 2024. Over the past year, it has increased by +$146.81 million (+32.10%). ASND TTM EBIT is now -14322.27% below its all-time high of $2.18 million, reached on 31 December 2013.ASND TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASND EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -2.4% | +32.1% |
| 3 y3 years | -3.5% | +33.2% | +28.8% |
| 5 y5 years | -91.6% | +9.6% | -32.9% |
ASND EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.5% | +19.3% | -43.6% | +60.2% | at high | +46.5% |
| 5 y | 5 years | -91.6% | +19.3% | -43.6% | +62.1% | -32.9% | +46.5% |
| alltime | all time | -7538.6% | +19.3% | -3768.4% | +62.1% | <-9999.0% | +46.5% |
Ascendis Pharma A/S EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$80.10 M(-16.9%) | -$310.54 M(-18.2%) |
| June 2024 | - | -$96.40 M(+72.8%) | -$379.67 M(-6.5%) |
| Mar 2024 | - | -$55.79 M(-28.7%) | -$405.98 M(-11.2%) |
| Dec 2023 | -$465.61 M(-19.3%) | -$78.25 M(-47.6%) | -$457.35 M(-21.2%) |
| Sept 2023 | - | -$149.23 M(+21.6%) | -$580.30 M(+3.6%) |
| June 2023 | - | -$122.70 M(+14.5%) | -$559.89 M(+9.0%) |
| Mar 2023 | - | -$107.16 M(-46.7%) | -$513.80 M(-5.1%) |
| Dec 2022 | -$577.01 M(+28.3%) | -$201.20 M(+56.2%) | -$541.13 M(+17.7%) |
| Sept 2022 | - | -$128.82 M(+68.1%) | -$459.84 M(+8.3%) |
| June 2022 | - | -$76.62 M(-43.0%) | -$424.72 M(-14.3%) |
| Mar 2022 | - | -$134.49 M(+12.2%) | -$495.50 M(+13.7%) |
| Dec 2021 | -$449.65 M(-5.6%) | -$119.91 M(+28.0%) | -$435.85 M(-17.4%) |
| Sept 2021 | - | -$93.69 M(-36.4%) | -$527.52 M(-0.4%) |
| June 2021 | - | -$147.39 M(+96.9%) | -$529.47 M(+11.4%) |
| Mar 2021 | - | -$74.85 M(-64.6%) | -$475.41 M(+1.1%) |
| Dec 2020 | -$476.52 M(+96.1%) | -$211.58 M(+121.2%) | -$470.02 M(+35.4%) |
| Sept 2020 | - | -$95.65 M(+2.5%) | -$347.02 M(+24.4%) |
| June 2020 | - | -$93.33 M(+34.4%) | -$278.96 M(+15.1%) |
| Mar 2020 | - | -$69.46 M(-21.6%) | -$242.33 M(+3.7%) |
| Dec 2019 | -$242.96 M | -$88.58 M(+221.1%) | -$233.65 M(+28.7%) |
| Sept 2019 | - | -$27.58 M(-51.4%) | -$181.57 M(-6.2%) |
| June 2019 | - | -$56.70 M(-6.7%) | -$193.56 M(+17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$60.79 M(+66.5%) | -$164.16 M(+12.7%) |
| Dec 2018 | -$153.94 M(+9.4%) | -$36.50 M(-7.7%) | -$145.72 M(-10.2%) |
| Sept 2018 | - | -$39.56 M(+44.9%) | -$162.24 M(+1.7%) |
| June 2018 | - | -$27.31 M(-35.5%) | -$159.49 M(+0.2%) |
| Mar 2018 | - | -$42.35 M(-20.1%) | -$159.15 M(+12.3%) |
| Dec 2017 | -$140.74 M(+85.0%) | -$53.03 M(+44.1%) | -$141.76 M(+29.1%) |
| Sept 2017 | - | -$36.81 M(+36.5%) | -$109.80 M(+18.0%) |
| June 2017 | - | -$26.97 M(+8.0%) | -$93.05 M(+14.6%) |
| Mar 2017 | - | -$24.96 M(+18.5%) | -$81.17 M(+6.9%) |
| Dec 2016 | -$76.06 M(+104.2%) | -$21.07 M(+5.1%) | -$75.93 M(+6.5%) |
| Sept 2016 | - | -$20.05 M(+32.8%) | -$71.29 M(+20.4%) |
| June 2016 | - | -$15.09 M(-23.4%) | -$59.23 M(+1.6%) |
| Mar 2016 | - | -$19.72 M(+20.0%) | -$58.32 M(+57.9%) |
| Dec 2015 | -$37.25 M(+171.3%) | -$16.43 M(+105.6%) | -$36.94 M(+32.6%) |
| Sept 2015 | - | -$7.99 M(-43.7%) | -$27.87 M(+24.5%) |
| June 2015 | - | -$14.19 M(-951.2%) | -$22.38 M(+102.6%) |
| Mar 2015 | - | $1.67 M(-122.7%) | -$11.05 M(-17.2%) |
| Dec 2014 | -$13.73 M(-319.3%) | -$7.35 M(+193.0%) | -$13.35 M(+250.3%) |
| Sept 2014 | - | -$2.51 M(-12.0%) | -$3.81 M(+193.0%) |
| June 2014 | - | -$2.85 M(+350.5%) | -$1.30 M(-183.9%) |
| Mar 2014 | - | -$632.90 K(-129.0%) | $1.55 M(-29.0%) |
| Dec 2013 | $6.26 M(+273.1%) | $2.18 M | $2.18 M |
| Dec 2012 | $1.68 M | - | - |
FAQ
- What is Ascendis Pharma A/S annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
- What is Ascendis Pharma A/S TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM EBIT year-on-year change?
What is Ascendis Pharma A/S annual earnings before interest & taxes?
The current annual EBIT of ASND is -$465.61 M
What is the all time high annual EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual earnings before interest & taxes is $6.80 M
What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
The current quarterly EBIT of ASND is -$80.10 M
What is the all time high quarterly EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly earnings before interest & taxes is $2.18 M
What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
Over the past year, ASND quarterly earnings before interest & taxes has changed by -$1.85 M (-2.36%)
What is Ascendis Pharma A/S TTM earnings before interest & taxes?
The current TTM EBIT of ASND is -$310.54 M
What is the all time high TTM EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM earnings before interest & taxes is $2.18 M
What is Ascendis Pharma A/S TTM EBIT year-on-year change?
Over the past year, ASND TTM earnings before interest & taxes has changed by +$146.81 M (+32.10%)